Merrimack Pharmaceuticals Inc. (MACK) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE BROADWAY
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:19,40014,20014,00016,60071,30093,441
Cash and cash equivalents19,43914,20314,03816,58020,07993,441
Short-term investments    51,199 
Other undisclosed cash, cash equivalents, and short-term investments(39)(3)(38)2022 
Restricted cash and investments     584102
Receivables      100
Other undisclosed current assets4284832,5442,0924,2181,403
Total current assets:19,82814,68316,54418,69276,10295,046
Noncurrent Assets
Property, plant and equipment     2,2696,467
Long-term investments and receivables     7,42810,551
Long-term investments     7,42810,551
Restricted cash and investments      674
Other noncurrent assets8662321,3902,7444,588
Total noncurrent assets:8662321,39012,44122,280
TOTAL ASSETS:19,83614,74916,77620,08288,543117,326
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5895627702,71413,67717,606
Interest and dividends payable    19
Taxes payable   83 
Employee-related liabilities   2,3152,884
Accounts payable1881201232711,0342,887
Accrued liabilities1391671943722,0825,663
Other undisclosed accounts payable and accrued liabilities2622754532,0718,1636,153
Deferred rent credit     1,118
Other liabilities    56  
Deferred revenue and credits2,171
Total current liabilities:5895627702,77014,79519,777
Noncurrent Liabilities
Long-term debt and lease obligation     14,873 
Long-term debt, excluding current maturities     14,873 
Liabilities, other than long-term debt     561,265
Deferred revenue and credits1,209
Other liabilities     5656
Total noncurrent liabilities:     14,9291,265
Total liabilities:5895627702,77029,72421,042
Equity
Equity, attributable to parent19,24714,18716,00617,31258,81996,284
Common stock1,3421,3341,3341,3341,3341,334
Additional paid in capital565,541558,945558,309556,587580,771577,721
Accumulated other comprehensive loss     (9) 
Accumulated deficit(547,636)(546,092)(543,637)(540,609)(523,277)(482,771)
Total equity:19,24714,18716,00617,31258,81996,284
TOTAL LIABILITIES AND EQUITY:19,83614,74916,77620,08288,543117,326

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues    4,910 1,703
Gain on disposition of assets for financial service operations    4,910 
Financial services revenue1,703
Gross profit:    4,910 1,703
Operating expenses(1,729)(2,472)(2,873)(22,359)(65,575)(105,287)
Other undisclosed operating income (loss)    (4,910) 7,818
Operating loss:(1,729)(2,472)(2,873)(22,359)(65,575)(95,766)
Nonoperating income (expense)18820(141)(381)(2,887)10,310
Investment income, nonoperating18820507771,29911,743
Other nonoperating income (expense)   (191)370(3,230)(1,433)
Interest and debt expense    (971)(956)(34,650)
Loss from continuing operations before equity method investments, income taxes:(1,541)(2,452)(3,014)(23,711)(69,418)(120,106)
Other undisclosed income from continuing operations before income taxes    9719561,703
Loss from continuing operations before income taxes:(1,541)(2,452)(3,014)(22,740)(68,462)(118,403)
Income tax expense (benefit)(3)(3)(14)1,4737,69542,399
Loss from continuing operations:(1,544)(2,455)(3,028)(21,267)(60,767)(76,004)
Income (loss) before gain (loss) on sale of properties:(2,455)(3,028)(17,332)(40,506)470,868
Income from discontinued operations    3,93520,261546,872
Net income (loss):(1,544)(2,455)(3,028)(17,332)(40,506)470,868
Net income attributable to noncontrolling interest      1,160
Net income (loss) available to common stockholders, diluted:(1,544)(2,455)(3,028)(17,332)(40,506)472,028

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(1,544)(2,455)(3,028)(17,332)(40,506)470,868
Comprehensive income (loss):(1,544)(2,455)(3,028)(17,332)(40,506)470,868
Comprehensive income, net of tax, attributable to noncontrolling interest      1,160
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    9(9) 
Comprehensive income (loss), net of tax, attributable to parent:(1,544)(2,455)(3,028)(17,323)(40,515)472,028

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: